Inspire Medical Systems, INC Form 4 insider transactions

NYSE
CEO Timothy Herbert sold shares of Inspire Medical Systems (INSP) on April 1, 2024, through a series of transactions at prices ranging from approximately $203 to $213.
NYSE
Director Jerry C. Griffin exercised stock options and sold a small portion of the acquired shares of Inspire Medical Systems under a pre-arranged Rule 10b5-1 trading plan.
NYSE
Marilyn C. Nelson, a director of Inspire Medical Systems, exercised stock options and disposed of shares on April 1, 2024.
NYSE
Director Marilyn Nelson reports exercising stock options and acquiring shares of Inspire Medical Systems, Inc.
NYSE
Director Jerry C. Griffin of Inspire Medical Systems, Inc. reports exercising stock options and selling shares under a pre-arranged Rule 10b5-1 trading plan.
NYSE
John Rondoni, Chief Technology Officer of Inspire Medical Systems, sold a total of 4,387 shares of common stock on March 22, 2024, under a pre-arranged Rule 10b5-1 trading plan.
NYSE
Director Jerry C. Griffin exercised stock options and sold shares of Inspire Medical Systems, Inc. under a pre-arranged 10b5-1 trading plan.
NYSE
Director Jerry C. Griffin exercised stock options and sold shares of Inspire Medical Systems, Inc. under a pre-arranged 10b5-1 trading plan.
NYSE
Director Jerry C. Griffin exercised stock options and sold shares of Inspire Medical Systems, Inc. under a pre-arranged 10b5-1 trading plan.
NYSE
Director Marilyn Nelson exercised stock options and acquired shares of Inspire Medical Systems, Inc. on March 1, 2024.
NYSE
John Rondoni, Chief Technology Officer of Inspire Medical Systems, sold a portion of his common stock holdings on February 29, 2024, under a pre-arranged Rule 10b5-1 trading plan.
NYSE
Chief Commercial Officer Randy Ban of Inspire Medical Systems reports exercising stock options and selling shares, while also reporting indirect ownership through family members.